Document is current

Any future updates will be listed below

Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-015-0685-2

Published Online: 2015-04-10

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark